Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients
{{output}}
Background: Osimertinib is an epidermal growth factor receptor-tyrosine kinase inhibitor that specifically targets the T790M mutation in cancer.Unfortunately, most non-small cell lung cancer (NSCLC) patients develop osimertinib r... ...
